Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-30T15:40:28.886Z Has data issue: false hasContentIssue false
  • English
  • Français

Impact of neuropsychiatry screening in neurological in-patients: comparison with routine clinical practice

Published online by Cambridge University Press:  24 June 2014

Justin Earl ,
Olimpia Pop ,
Kate Jefferies  and
Niruj Agrawal
Justin Earl*
Affiliation:
South West London and St George's Mental Health NHS Trust, London, UK
Olimpia Pop
Affiliation:
South West London and St George's Mental Health NHS Trust, London, UK
Kate Jefferies
Affiliation:
Farnham Road Hospital, Guildford, UK
Niruj Agrawal
Affiliation:
Department of Neuropsychiatry, St George's Hospital, London, UK
*
Dr Justin Earl, South West London and St George's Mental Health NHS Trust, London, UK. Tel: 0208 682 6000; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Extract

Earl J, Pop O, Jefferies K, Agrawal N. Impact of neuropsychiatry screening in neurological in-patients: comparison with routine clinical practice

Background: It is now well recognised that the rate of psychiatric comorbidity is high in patients with neurological disorders. Psychiatric comorbidity has a significant impact on quality of life and often goes undetected in routine clinical practice.

Objectives: To compare the rate of detection of psychiatric illness in routine clinical practice with the prevalence of mental illness established using a dedicated screening programme at a regional neuroscience centre and to assess if the screening programme had any enduring impact on routine clinical practice after its completion.

Methods: Consecutive admissions to a neurology ward in the 3-month period before (n = 160) and after (n = 158) a dedicated neuropsychiatric screening programme was carried out were identified. Case notes were then reviewed to establish if symptoms of mental illness were identified by the treating neurologists and if patients were referred for neuropsychiatric assessment. Rates of detection of neuropsychiatric problems and rates of referral for treatment were compared with those identified during the screening programme.

Results: In routine clinical practice, over two 3-month study periods, psychiatric symptoms were identified in 23.7% of patients and only 10.6% received neuropsychiatric interventions. This is much lower as compared with rates identified (51.3%) and treated (51.3%) during dedicated screening. Detection of mood symptoms decreased from 14.7% pre-screening to 3.8% in the post-screening period.

Conclusion: Rate of detection and treatment of neuropsychiatric problems remain low in neurology in-patients in routine clinical practice. Neuropsychiatric screening is effective but does not have sustained effect once it stops. Hence we suggest that active ongoing screening should be incorporated into routine practice.

Keywords

affective disordercomorbiditydepressionpsychiatric disorders
Type
Research Article
Information
Acta Neuropsychiatrica , Volume 23 , Issue 6 , December 2011 , pp. 297 - 301
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Hansen, M, Fink, P, Frydenberg, M, Oxhoj, M, Sondergaard, L, Munk-Jorgensen, P.Mental disorders among internal medical inpatients. Prevalence, detection, and treatment status. J Psychosom Res 2001;50:199–204CrossRefGoogle ScholarPubMed
2.Silverstone, P.Prevalence of psychiatric disorders in medical inpatients. J Nerv Ment Dis 1996;184:43–51.CrossRefGoogle ScholarPubMed
3.Fink, P, Hansen, MS, Sondergaard, L, Frydenberg, M.Mental illness in new neurological patients. J Neurol Neurosurg Psychiatry 2003;74:817–819.CrossRefGoogle ScholarPubMed
4.Bridges, K, Goldberg, D.Psychiatric illness in inpatients with neurological disorders: patients' views on discussion of emotional problems with neurologists. Br Med J 1984;289:656–658.CrossRefGoogle ScholarPubMed
5.de Jonge, P, Huyse, F, Herzog, T et al. Referral pattern of neurological patients to psychiatric Consultation-Liaison Services in 33 European hospitals. Gen Hosp Psych 2001;23:152–157.CrossRefGoogle ScholarPubMed
6.Jefferies, K, Owino, A, Rickards, H, Agrawal, N.Psychiatric disorders in neurology inpatients: estimates of prevalence and usefulness of screening questionnaires. J Neurol Neurosurg Psychiatry 2007;78:414–416.CrossRefGoogle ScholarPubMed
7.Boylan, LS, Flint, LA, Labovitz, DL, Jackson, SC, Starner, K, Devinsky, O.Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004;62:258–261.CrossRefGoogle Scholar
8.The Global Parkinson's Disease Survey (GPDS) Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002;17:60–67.CrossRefGoogle Scholar
9.Richard, IH, Kurlan, R.The under-recognition of depression in Parkinson's disease. Neuropsychiatr Dis Treat 2006;2:349–353.CrossRefGoogle ScholarPubMed
10.Kanner, AMDepression and epilepsy: a new perspective on two closely related disorders. Epilepsy Curr 2006;6:141–146.CrossRefGoogle ScholarPubMed